purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation mdt earnings call period ending december image source motley fool medtronic mdt q earnings callfeb etcontents prepared remark question answer call participant prepared remark ryan weispfenning good morning welcome minnesota finally snow ryan weispfenning vice president head medtronic investor relation appreciate joining u morning fiscal third quarter video earnings webcast go inside hear prepared remark share detail today webcast joining geoff martha medtronic chairman chief executive officer karen parkhill medtronic chief financial officer geoff karen provide comment result third quarter ended january outlook remainder fiscal year prepared remark executive vps covering segment join u take question sellside analyst cover company today program last hour earlier morning issued press release containing financial statement divisional geographic revenue summarieswe also posted earnings presentation provides additional detail performance presentation accessed earnings press release website investorrelationsmedtroniccom today program many statement make may considered forwardlooking statement actual result may differ materially projected forwardlooking statement additional information concerning factor could cause actual result differ contained periodic report filing make sec undertake update forwardlooking statement unless say otherwise comparison yearoveryear basis revenue comparison made organic basis excludes impact foreign currency third quarter revenue current priory ear reported stem prior business separation acquisition made last four quarter significant impact total company individual segment quarterly revenue growth reference sequential revenue change compared second quarter fiscal made asreported basis reference share gain loss refer revenue share fourth calendar quarter compared fourth calendar quarter unless otherwise stated reconciliation nongaap financial measure found earnings press release website investorrelationsmedtroniccom finally eps guidance include charge gain would reported nongaap adjustment earnings fiscal year let u head studio hear quarter commercial break geoff martha chairman chief executive officer hi everyone thank joining u today momentum solid execution continued quarter established track record consistently delivering midsingledigit organic revenue growth diabetes took another step forward doubledigit growth supported return growth yous would also note particular strength saw multiple business like core spine cardiac surgery structural heart cardiac pacing strong growth across international market expand access innovative healthcare technology around globe time rapid cadence new product approval continuing differentially invest pipeline highest growth opportunity advancing innovative core technology like robotics ai closedloop system five ai product already fdaapproved leading way bringing tech medtech also continue make progress comprehensive transformation company incorporating performancedriven culture based execution speed playing win leveraging scale drive efficiency look financials quarter seeing early result focus restoring earnings power converting earnings strong cash flow using cash invest highreturn opportunity return value shareholder executing delivering expect continue coming quarter year given momentum ongoing transformation breakthrough innovation exposure strong secular growth market numerous catalyst across business get detail q result want mention provided portfolio management update morning patient monitoring respiratory intervention business comprehensive review decided exit unprofitable ventilator product line retain bring together remaining pmri business one business calling acute care monitoring determined best interest medtronic stakeholder acm business near long term exit vent increasing unprofitability market preference shift loweracuity ventilator exit vent want recognize strong legacy business puritan bennett brand committed serving need customer honoring ventilator service contract also want thank employee ventilator business played incredible role pandemic dramatically expand production get ventilator community around world needed exit believe existing manufacturer meet customer demand new ventilator going forward time decided retain refocus remaining pmri business three main factor driven decision first strong conviction ability lead drive growth acute care monitoring given improved competitive position ability properly fund business saving exiting vent second importance data space changing rapidly becoming basis innovation fact improves competitive differentiation lastly company broadly continue prioritize profitable innovationdriven growth category leadership acm deliver mean shy away additional portfolio move going forward bar high strategic activity dilutes focus profit growth take decision together able provide increased investment acute care monitoring using saving vent bringing two business together without creating dilution pl let u get detail behind q result continue look portfolio three category established market leader synergistic highestgrowth business quarter three grew line expected growth algorithm established market leader synergistic business grew midsingle digit highest growth business posted high singledigit growth expect contribution overall growth accelerate quarter ahead looking first established market leader combined made half revenue grew starting cranial spinal technology driving consistent abovemarket growth continued adoption aible ecosystem cst delivered high singledigit growth core spine midteens growth biologics high singledigit growth enabling technology strong doubledigit unit growth stealth station navigation oarm imaging mazor robotic system leading indicator future growth business also continue see strong adoption unid adaptive spine intelligence integrated aibased surgical planning solution aible offering complete robust ecosystem enabling technology associated implant spine surgeon global footprint includes system four time greater nearest competitor scale extensive rapidly increasing install base transforming spine industry leading way surgeon adopt integrated spine technology environment disruption consolidation attracting best sale team medtronic grow expand business next surgical grew wound management business share growing high teen strength vloc barbed suture also solid midsingle digit growth hernia product share synthetic permanent mesh progrip platform expected surgical growth continue modest impact decline bariatric surgery still believe impact temporary patient become eligible surgery patient seek permanent treatment weight loss wrap established market leader cardiac rhythm also grew driven high singledigit growth cardiac pacing micra leadless pacemaker continued post strong result growing driven launch nextgeneration micra av vr device also benefiting adoption conduction system pacing alternative traditional single dualchamber pacing lead one market approved conduction system pacing continued grow strong double digit crm also began training limited launch aurora evicd expect evicd reaccelerate defibrillation solution growth coming quarter shared past aurora game changer icd space delivers benefit traditional icd including similar size longevity pacing feature without lead harder vein benefit realized one device one implant procedure expect advantage displace competitor device expand population far beyond existing segment strong growth driver crm turning synergistic business combined grew midsingle digit q highlight driver let u start aortic grew supply recovery continued momentum endurant aaa franchise cardiac surgery grew driven strength perfusion cannula ecls oxygenators given competitor quality issue strong sale international market avalus surgical valve coronary grew driven doubledigit growth guide catheter balloon increased drugeluting stent share yous europe continued rollout onyx frontier drugeluting stent turning business highestgrowth market mentioned earlier together business grew high single digit quarter expect contribution growth accelerate going forward diabetes led way growing double digit global adoption gamechanging minimed g system seeing strong sequential momentum growing prior quarter customer base growing sequentially driving revenue per customer yous return growth grew midsingle digit driven nearly revenue growth insulin pump doubled new user year year attracting multiple daily injection well user competitor system user choosing g outcome delivers intensive insulin user outcome matter g highly differentiated aid system automatically adjust correct sugar every five minute offer flexible glucose target low feature proprietary meal detection technology lead high time range user type glycemic control coming le effort burden user realize relief come spending time automation smartguard technology worth pointing recent thirdparty survey nearly yous diabetes pump user g scored overall pump satisfaction among type cgm user guardian sensor mirrored competitor sensor overall satisfaction quarter secured ce mark simplera sync sensor use g look begin limited release spring yous planning submit g simplera sync fda first half calendar year simplera sync half size current sensor disposable design much easier put driving diabetes turnaround time got tell certainly feel really good return doubledigit growth finished definitely work done work bring market even robust ecosystem differentiated technology people living diabetes including nextgeneration durable pump smart pen patch pump sensor algorithm intensive insulin management space move using smart dosing either aid smart mdi expect acceleration growth contribution diabetes business turning cardiac ablation solution delivered growth international market including growth western europe strong international growth well overall performance continues driven leading arctic front cryo solution pulsefield ablation still early stage seeing though lot enthusiasm market pfa product europe company pfa offering single shot focal segment single shot started limited market release pulseselect pfa system fiscal q seeing efficient procedure couple case learning curve really short catheter handling maneuverability excellent due small shaft custom french bidirectional sheath clinician also reporting noticeable muscle contraction pfa product beneficial patient experience focal continued ramp manufacturing affera mapping system sphere catheter remain limited market release europe sphere catheter perform pulse field ablation radiofrequency ablation highdensity mapping really allinone catheter yous ca business declined quarter faced first full quarter competition cryoablation space space created player addition many customer actually held back purchase awaited launch pulseselect pfa catheter commercially available expect improve roll recently approved nextgeneration nitron cryoconsole pulseselect pfa catheter fdaapproved paroxysmal persistent af addition european feedback clinician consistently commented well visualized easily connects mapping system also making progress bringing aferra mapping system sphere catheter yous last patient followup sphere peraf pivotal trial completed expect see result medical meeting first half calendar year billion market size expanding share underpenetrated cardiac ablation space big opportunity u expect growth profile improve time first moving toward market growth winning share bring rich pipeline innovation patient need technology neurovascular quarter grew high single digit exclude sale china market subject volumebased procurement continue strong doubledigit growth flow diversion globally driven innovative shield technology treating brain aneurysm available pipeline flex vantage flow diverters robotics surgical technology continued growing install base differentiated hugo robotic system international market yous expand uro pivotal trial continues enroll expect first enrollment hernia trial soon expect hugo equipped advanced digital capability meaningful growth driver u year ahead believe surgeon preference open console modular design leading position minimally invasive surgery instrumentation connected digital ecosystem dataenabled insight along worldclass surgical training program partnership meaningfully advance low penetration robotic surgery around world turning structural heart grew high single digit quarter including midsingle digit sequentially see ongoing adoption evolut fx improved design marketleading valve performance europe fx launched first full quarter grew double digit japan grew low continued adoption fx pleased share news today submitted evolut fx plus fda approval fx plus three window frame allow easy coronary access providing dependable valve performance evolut platform also pleased hear oneyear trial result smart trial presented latebreaker acc april excited see result looking forward fx plus smart trial well continued strength fouryear lowrisk data catalyst structural heart business let u go karen deeper look q financial performance fiscal guidance raise karenkaren parkhill executive vice president chief financial officer looking financials third quarter another quarter delivered commitment revenue grew ahead expectation adjusted eps midpoint guidance range attribute beat strongerthanexpected revenue growth gross margin offset greaterthananticipated currency impact primarily devaluation argentine peso december delivering durable midsingledigit revenue growth several quarter geoff mentioned international market important driver u nonyous developed market grew including growth western europe growth japan fact doubledigit growth several business across region emerging market grew high teen growth middle east africa midteens growth south asia china grew low double digit vbp expected continues delayed eastern europe grew low single digit given russian sanction yous grew several new product approval earliest stage launch expect launch positively impact yous growth next couple quarter beyond looking pl delivered strong quarter adjusted gross operating margin ahead expectation adjusted gross margin improved year year overcoming basispoint headwind foreign exchange continued elevated inflation attribute favorability primarily delayed china vbp lower freight cost also continue see traction pricing effort early benefit comprehensive cog efficiency effort adjusted operating margin declined basis point entirely driven currency fact operating margin constantcurrency basis basis point improvement gross margin strong sga leverage continue drive efficiency across enterprise operating margin line adjusted tax rate little higher anticipated mainly due jurisdictional mix profit flip side income investment also little better expected higher rate worth noting adjusted eps flat year year grew constantcurrency basis leverage drove pl also significantly improved free cash flow conversion quarter turning guidance given top bottomline beat continued strength underlying fundamental raising fullyear revenue eps guidance expect fullyear organic revenue growth fourth quarter expecting organic revenue growth range compadjusted basis acceleration third quarter continue ramp recent product launch exit ventilator announced today moving associated revenue segment starting fourth quarter case revenue exclude organic revenue growth additional detail found third quarter earnings presentation regarding currency based recent rate would see fullyear revenue impact range unfavorable million favorable million including unfavorable impact million million fourth quarter bottom line beat third quarter raising fullyear eps guidance midpoint new range would point given durable performance able increase guidance midpoint initially started year fourth quarter expect adjusted eps regarding currency based recent rate seeing unfavorable impact fullyear eps including unfavorable impact fourth quarter lastly give fiscalyear guidance earnings call may finish planning want share early thought seen u deliver durable revenue growth several quarter expect continue pl inflation currency tax currently headwind earnings growth expect continue increase investment rd said focused driving offset improving earnings power company regarding portfolio management decision announced today street fy number yet reflect potential separation today decision able increase investment innovationdriven growth without nearterm earnings dilution ongoing impact cash flow focus optimizing longterm shareholder value want close expressing sincere gratitude employee hard work unwavering commitment medtronics mission dedication instrumental achieving result quarter making difference many people around world thank geoff turning back take homegeoff martha chairman chief executive officer ok thank wrap want note tom holleran passed away last week age tom provided decade leadership company first general counsel next president director board many many year early tom one instrumental people created medtronic mission together founder earl bakken tom also significant leader twin city beyond served several company board thought tom family celebrate life go analyst question close brief concluding comment progress seen several quarter row delivering commitment durable midsingledigit revenue growth look last couple quarter rapid cadence meaningful innovative product approval many getting started including evicd pulseselect affera pfa inceptiv sc percept rc db course new simplera sync sensor diabetes forget symplicity hypertension combine investment enter surgical robotics along strong execution business like spine diabetes give u confidence ability continue delivering durable growth time sharing effort restore earnings power company seeing effort begin show financials comprehensive transformation working streamlining operating model aligning incentive revamping capital portfolio management activity instilling performancedriven culture well also impact change take time certainly done encouraging see progress stand today equal exciting catalyst see coming believe lead significant advancement patient value creation healthcare system around world shareholder let u move qa going try get many analyst possible operator instruction additional question reach ryan investor relation team call brad please give instruction asking questionbrad welnick vice president investor relation operator instruction lastly please advised qa session recorded today session geoff karen ryan joined que dallara evp president diabetes mike marinaro evp president medical surgical portfolio sean salmon evp president cardiovascular portfolio brett wall evp president neuroscience portfolio operator instructionsryan weispfenning take first question larry biegelsen well fargo larry please go aheadlarry biegelsen well fargo security analyst good morning thanks taking question congratulation another nice quarter wanted focus one question fiscal comment geoff karen talked durable growth think midsingledigit organic growth help u think concern seeing afib business given low doubledigit decline yous put take consider earnings karen quantify headwind inflation tax fx fiscal consensus comfortable consensus eps growth thank taking questiongeoff martha chairman chief executive officer well first thanks question larry maybe start ca one karen maybe sean take afib one karen talk fy question going phone friend sean second afib business look confident investment made going bear fruit seen translate financials yet lot leading indicator seeing give u confidence one continued think stronger performance people might think cryo importantly pfa pulseselect organic program affera sean want comment little specifically larrysean salmon executive vice president president cardiovascular portfolio yeah sure geoff larry yous experienced first time ever competitor cryo segment market share competitor ramp production felt fourth quarter think also interest patient new product launching including nitron console refresh capital equipment cryo course pulseselect started launch united state quarter closed well feedback exceptional well united state well outside united state think catalyst growth pulse field pulseselect singleshot technology well pointbypoint ablation driving lot enthusiasm think going see return growth next year really feel full force launch step back certainly united state growth worldwide outside united state say giving u lot confidence pipeline poised return u growth segmentgeoff martha chairman chief executive officer thanks seankaren parkhill executive vice president chief financial officer fy larry would start fact really pleased performance last several quarter q another solid quarter fifth consecutive quarter solid midsingle digit would point drove midsingledigit growth quarter midsingledigit comp last year expect continue fy working planning process expect wrap advance q earnings call give guidance may ready give real specific high level major change put take next year discussed earnings call q focused obviously setting guidance set u success prioritizes innovation allows u deliver commitment margin pl put take got inflation stabilizing bit still higher historical currency always dynamic recent rate facing decent headwind fx see shake global tax reform likely headwind always focused driving offset know made good real progress cog cost work started centralizing global ops supply chain focusing team putting place tangible program place drive cost work always continuing focus driving pricing important lever built new muscle around pricing making stronger stronger always focused controlling expense got discipline largest driver expense headcount expect continue really major change laid last quarterryan weispfenning ok thanks larry operator instruction brad take next question pleasebrad welnick vice president investor relation next question come robbie marcus jp morgan robbie please go aheadrobbie marcus jpmorgan chase company analyst great thanks good morning everyone wanted ask patient monitoring business original intent try sell spin keeping exiting ventilator business maybe walk u thought process happened market best outcome medtronic thanksgeoff martha chairman chief executive officer sure take one robbie couple thing start couple thing changed start strong conviction driving profitable category leadership calling acute care monitoring business couple dynamic changed reminder monitoring component patient monitoring component biggest part business intended spin think biggest thing change improved competitive positioning monitoring business particular changed last year working process continue run business performed well competitive dynamic versus main competitor masimo changed significantly positive u believe ensure change durable increased investment found way make increased investment lead decision wind vent business difficult decision business became increasingly unprofitable throughout last year growth slowed even dynamic within vent segment changing moving lower acuity ventilator kind would say unique worthy contribution higher acuity hospital based market changing becoming increasingly unprofitable decision wind creates oxygen investment fund monitoring side equation ensure competitive positioning versus masimo feel like extend another dynamic emerged use data importance data space changing becoming increasing actually would say basis innovation confidence taking data translating meaningful iteration rapid iteration well disruption time pretty high given able ai part company add together try last thing make comment company broadly continue prioritize profitable growth category leadership take factor together believe able provide increased investment acute care monitoring business call acm using saving vent also bringing two two separate business respiratory intervention business ventilator monitoring business bringing together leadership level also creates saving fund incremental investment needed monitoring business without dilution pl last thing want say difficult decision take anything away employee play pivotal role covid driving ventilator innovation responding global need covid pandemic also want give nod legacy brand strong proud rich legacy business ventilator decision easy last thing say mean going shy away additional portfolio move read anything bar high strategic activity going dilute focus earningsryan weispfenning ok thank robbie take next question please bradbrad welnick vice president investor relation next question come joanne wuensch citi joanne please go aheadjoanne wuensch citi analyst good morning thank taking question lot product could ask going throw couple headline one diabetes congratulation return yous growth way peel apart little bit new account new patient versus renewal thanks guess second question hugo give u little bit state update launch going outside united statesgeoff martha chairman chief executive officer well thanks joanne question obviously working diabetes turnaround time straight line definitely momentum g platform capability use like talking patient monitoring business well create algorithm really differentiated drive differentiated outcome patient playing globally united state que maybe que could come answer joannes could peel little part little bit joanne would appreciate itque dallara executive vice president president diabetes portfolio yes look pleased progress made every quarter since launched seeing new patient grow significantly well renewal progressing well look take time rebuild installed base see pump growth saw yous high year year going followed consumables cgm growth well expect continue make progress every quarter pretty pleased market reacted product introductiongeoff martha chairman chief executive officer ok thanks que mike marinaro jump hugo heremike marinaro executive vice president president surgical endoscopy portfolio yeah thanks joanne question continue see good progress hugo outside united state expansion installation country around globe fact entered two new subregions central eastern europe continuing see good response thing talked previously open console crisp visualization increasingly good feedback around touch surgery enterprise platform continues expand good quarter installation hugo broader surgical business also geoff noted commentary continued good progress expand euro ide yous preparing first patient enrollment hernia ide total good reception sharpening sort appreciation feature hugo think emergence digital ecosystem appreciation wellgeoff martha chairman chief executive officer yeah would say joanne one thanks mike first would say one robotic system feature well received broader mike pointed mean digital platform come well instrumentation transition instrumentation laparoscopic business onto robot particularly stapling energy move build momentum build capability momentum time seeing saw play spine business bought mazor overnight change saw last couple quarter took integration thing mazor navigation imaging getting ai guided surgical planning system thing coming together every quarter progress built ecosystem today really driving growth medtronic growth spine industry right expect thing soft tissue surgeryryan weispfenning ok thank joanne take next question please bradbrad welnick vice president investor relation next question come travis steed bank america travis please go aheadtravis steed bank america merrill lynch analyst hey thanks taking question hear okgeoff martha chairman chief executive officer yeah hey travis doingtravis steed bank america merrill lynch analyst good good hey geoff curious could talk little bit gross margin productivity thing driving still get kind two three time annual cost saving gross margin line last month investor comment talked lot leverage growth curious comment applies fy longerterm commentgeoff martha chairman chief executive officer sure let tell start transition karen gross margin couple thing would point one pricing karen talked think seeing lot innovation industry lot medtronic innovation finding valued drive value health system think gotten better showing health economics innovation applies innovation addition clinical value think past pretty indexed clinical value recently keep focus add health economics getting paid think better job making point getting pricing think durable pricing increased would say company overall basis point relative past think going keep pushing even converse innovation prepared well think hospital gotten sophisticated purchasing price going pay keeping innovation given productlike goal given pricing loss feel good especially historical baseline asked cost good sold productivity answer short answer question yes think sustainable got lot opportunity think pretty big footprint factory distribution center many supplier said past greg smith coming couple year ago centralized take strategic look across portfolio long list costdown program ensured effectively contracted global operation supply chain team operating unit take release product engineering make sure cost program happen operating unit feel good feel sustainable two big change impact positively gross margin future speaking future turn karen talk fy leverage questionkaren parkhill executive vice president chief financial officer yeah add gross margin pleased performance quarter overcame basispoint headwind fx continued inflationary pressure lot driven strong pricing geoff talked continued delay china vbps aortic peripheral vascular stapling vbps could coming coming fourth quarter current fourth quarter potentially next year something going gross margin talk think leverage pl clearly focused driving leverage think talked last quarter travis clear leverage bottom line grows faster top line focused getting eventually ready talk fy still early planning guidance already pointed lot different put take next yeargeoff martha chairman chief executive officer yeah like karen mentioned pricing gross margin side pricing cost good productivity lot focus karen mentioned earlier call discipline around ga people driver cost put discipline holding finally setting portfolio profitable growth decision changing dynamic decision hold monitoring business confidence profitable growth evidence setting portfolio right way leave focus recovering earnings power company provide detail fy look next quarterryan weispfenning ok thank travis next question bradbrad welnick vice president investor relation next question come vijay kumar evercore isi vijay please go aheadvijay kumar evercore isi analyst hi guy thanks taking question guess one earnings question look peer earnings grown versus fiscal prepandemic level medtronic earnings essentially flattish medtronic commit perhaps trend earnings growth medium term play catch similar peer done think related geoff past mentioned million drag investment ardian hugo investment still drag profitable businessgeoff martha chairman chief executive officer thanks vijay question start latter question ardian hugo let karen handle earnings growth one comment ardian hugo would say look hugo way looking hugo part broader surgical franchise important part need investment look hugo specifically taking meaningful amount investment keep going reached love milestone term robot performing well got great feature valued physician globally feedback strong still got work got get instrument got complete yous trial got continue build yous capital equipment yous sale force tall order confidence executing high important huge business surgical business biggest business drive lot profit cash flow say confidence high know strong competitor intuitive like competitive positioning overall especially potential robotic company dynamic market think play favor investment ardian way really trying call symplicity got get get ready consumer education hypertension therapy trying get rid ardian term much possible got square jargon going around one hypertension one believe start show profit much le drag hope next couple quarter medium term generate revenue income highly profitable product line u high gross margin positive overall mix like said hugo going take investment one think provide oxygen next quarter two medium term leave turn karenkaren parkhill executive vice president chief financial officer yeah would say earnings made good progress driving earnings power company year noted able increase guidance bottom line midpoint initially started year driven strong track record drove driven last first three quarter year expect continue medium long term committed right earnings growth debate focused overcoming headwind got time frame delivering growthryan weispfenning thanks vijay probably time two question brad take two morebrad welnick vice president investor relation ok next question go matt miksic barclays matt please go aheadmatt miksic barclays analyst hi thanks much taking question hear okgeoff martha chairman chief executive officer yes nowmatt miksic barclays analyst great thank maybe followup product mentioned recently approved think product hope see approved coming quarter thinking like aurora pulseselect addition yous approved product diabetes know sean mentioned sort rough trajectory af ablation maybe business example additional color around cadence something start see improve fourth quarter sort like early mid kind process commentary sort cadence trajectory aurora example maybe diabetes business would super helpful thanksgeoff martha chairman chief executive officer sure maybe start sean turn sean pointed commentary put take ablation business call cardiac ablation solution afib business see acceleration business even fourth quarter turn sean talk afib aurorasean salmon executive vice president president cardiovascular portfolio yeah thanks geoff matt trajectory obviously going upward evicd well ca business total launch new technology training make sure physician comfortable use product course something deliberate make sure good patient outcome good acceptance technology something pretty frequently business really really good feedback excellent procedure efficiency pulseselect looking case done like half hour acceptance aurora exceptional said think story technology push growth next year see full impact innovationsgeoff martha chairman chief executive officer que want comment diabetesque dallara executive vice president president diabetes portfolio yeah look continue push pipeline diabetes starting simpler approved ce mark last september followed simplera sync recently approved announced jpmorgan completed clinical trial simplera sync yous expect submit first half calendar year cadence expect geoff mentioned opening comment nextgeneration product discussed ada last year continue make progress aggressively moving get nextgeneration tid pump patch come marketmatt miksic barclays analyst yeah thanksgeoff martha chairman chief executive officer thank thanks seanryan weispfenning thanks matt apologize analyst able get time though one bradbrad welnick vice president investor relation final question come anthony petrone mizuho security anthony please go aheadanthony petrone mizuho security analyst thanks hear okgeoff martha chairman chief executive officer yes yes cananthony petrone mizuho security analyst ok great one condolence passing tom team family maybe one going structural heart maybe set smart study quick twopart question one ahead schedule expected tct instead acc late breaker getting approved surprise maybe high level think study play result headtohead tavr highrisk symptomatic severe thought think data received postacc session coming week thanksgeoff martha chairman chief executive officer well thanks first anthony thanks comment tom holloran real legend around great guy going miss structural heart two comment turn sean first really applaud business evidence generation total lowrisk data publish every year convenient courage headtohead something often done space tell one love commitment data competitiveness go headtohead much looking forward result going come early april acc term specific asking might play turn seansean salmon executive vice president president cardiovascular portfolio yeah thanks anthony completement enrollment happened october month endpoint study push really window tct think schedule would say pleased accepted latebreaker acc really expected would say term trial received think momentum data notion year data lowrisk patient year showing superior durability valve compared surgical implant fouryear lowrisk study hard endpoint benefit widening benefit serious outcome like mortality disabling stroke course going headtohead really important patient population small said global market really prevalent among woman within smaller patient population like japan example think really important compelling data oneyear outcome portends longterm outcome think excited reception result think catalyst growth u really unique position particular subset patient big chunk market geoff martha chairman chief executive officer ok thanks sean wrap one final comment ventilation monitoring ventilation decision result portfolio decision bob white leaving medtronic impactful important leader company long time although friendship remain strong definitely going miss working day day want wish well know come board director executive committee everybody medtronic interacted bob high ethical leader good guy wish well term term today want thank everybody question definitely appreciate support continued interest medtronic hope join u q earnings broadcast anticipate holding thursday may update progress finish fiscal year also look ahead fiscal thanks spending time u today great rest day duration minutescall participantsryan weispfenninggeoff martha chairman chief executive officerkaren parkhill executive vice president chief financial officerbrad welnick vice president investor relationslarry biegelsen well fargo security analystsean salmon executive vice president president cardiovascular portfoliorobbie marcus jpmorgan chase company analystjoanne wuensch citi analystque dallara executive vice president president diabetes portfoliomike marinaro executive vice president president surgical endoscopy portfoliotravis steed bank america merrill lynch analystvijay kumar evercore isi analystmatt miksic barclays analystanthony petrone mizuho security analyst mdt analysis earnings call transcript article transcript conference call produced motley fool strive foolish best may error omission inaccuracy transcript article motley fool assume responsibility use content strongly encourage research including listening call reading company sec filing please see term condition additional detail including obligatory capitalized disclaimer liabilitythe motley fool recommends medtronic motley fool disclosure policy